SCYNEXIS (SCYX) expands authorized stock and registers 87M shares for resale
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
SCYNEXIS, Inc. is registering the resale of up to 87,000,000 shares of common stock under an effective Form S-3, covering shares already held by selling stockholders and shares issuable from existing warrants.
The company also amended its certificate of incorporation to increase authorized stock from 23,750,000 to 65,000,000 shares, including an increase in authorized common stock from 18,750,000 to 60,000,000 shares. Stockholders approved this change at the June 25, 2026 annual meeting, held before a 1-for-8 reverse stock split that took effect on May 29, 2026. Certain warrants become exercisable following the authorized share increase, with pre-funded warrants priced at $0.0001 per share and common warrants at $1.20 per share, all on a pre-split basis.
Positive
- None.
Negative
- None.
8-K Event Classification
4 items: 5.03, 5.07, 8.01, 9.01
4 items
Item 5.03
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Registered resale amount: 87,000,000 shares
Outstanding shares in resale: 34,750,000 shares
Pre-funded warrant shares: 8,750,000 shares at $0.0001/share
+5 more
8 metrics
Registered resale amount
87,000,000 shares
Common stock registered for resale under Form S-3, pre-split
Outstanding shares in resale
34,750,000 shares
Already issued common stock held by selling stockholders
Pre-funded warrant shares
8,750,000 shares at $0.0001/share
Common stock issuable from pre-funded warrants, pre-split
Common warrant shares
43,500,000 shares at $1.20/share
Common stock issuable from common warrants, pre-split
Authorized stock before/after
23,750,000 to 65,000,000 shares
Total authorized company stock increased via charter amendment
Authorized common stock before/after
18,750,000 to 60,000,000 shares
Authorized common shares increased in amended charter
Reverse stock split ratio
1-for-8
Reverse split effective May 29, 2026
Auditor ratification votes for
56,745,060 votes
Votes for ratifying Deloitte & Touche LLP
Key Terms
Certificate of Amendment, Registration Statement on Form S-3, pre-funded warrants, Common Warrants, +2 more
6 terms
Certificate of Amendment regulatory
"filed a Certificate of Amendment (the “Amendment”) to its Amended and Restated Certificate"
A certificate of amendment is an official filing that updates a company’s founding documents—its legal “rulebook” that sets share structure, voting rules, name and basic purpose. Think of it like changing the blueprint of a building: small changes are paperwork, big ones can alter who owns how much and who controls decisions. Investors watch these filings because they can affect share counts, voting power, dilution and company value.
Registration Statement on Form S-3 regulatory
"has filed with the Commission a Registration Statement on Form S-3 (Registration Statement No. 333-295493)"
A registration statement on Form S‑3 is a short, standardized filing a qualified public company uses to register new securities with regulators so they can be sold to investors; think of it as a pre-approved, reusable permission slip that speeds up future offerings. It matters to investors because it lets the company raise money more quickly and cheaply — which can fund growth or pay debt — but may also lead to share dilution or change in ownership, so it affects value and liquidity.
pre-funded warrants financial
"8,750,000 shares of Common Stock issuable upon the exercise of pre-funded warrants held by the Selling Stockholders"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
Common Warrants financial
"43,500,000 shares of Common Stock issuable upon the exercise of common warrants (the “Common Warrants”)"
A common warrant is a tradable instrument that gives its holder the right to buy a company’s common shares at a fixed price within a set time period, similar to a coupon that can be redeemed later to purchase stock. Investors care because exercising warrants can boost potential gains if the stock rises, but it can also dilute existing shareholders by increasing the number of shares outstanding, which can lower per-share value.
reverse stock split financial
"preceded the 1-for-8 reverse stock split that took effect on May 29, 2026"
A reverse stock split is when a company reduces the number of its shares outstanding, making each share more valuable. For example, if you own 100 shares worth $1 each, a 1-for-10 reverse split would turn your 100 shares into 10 shares worth $10 each. Companies often do this to boost their stock price and appear more stable to investors.
Annual Meeting of Stockholders regulatory
"held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”)"
FAQ
What capital changes did SCYNEXIS (SCYX) approve at the 2026 annual meeting?
SCYNEXIS stockholders approved an amendment increasing authorized stock to 65,000,000 shares, including 60,000,000 authorized common shares. This amendment, filed June 26, 2026, expands the company’s ability to issue equity in the future for corporate and financing purposes.
What are the exercise prices of SCYNEXIS (SCYX) warrants mentioned in the 8-K?
Pre-funded warrants are exercisable at $0.0001 per share, while common warrants carry a $1.20 per share exercise price. Both warrant series are held by selling stockholders and relate to shares registered for resale under SCYNEXIS’s effective Form S-3 registration statement.
When did SCYNEXIS (SCYX) implement its 1-for-8 reverse stock split?
SCYNEXIS implemented a 1-for-8 reverse stock split effective May 29, 2026. Voting results for the 2026 annual meeting and the share and warrant figures in the resale registration are presented using pre-reverse-split share counts and exercise prices for clarity.
Did SCYNEXIS (SCYX) stockholders approve the equity incentive plan changes?
Stockholders voted on an amendment to the 2024 Equity Incentive Plan, with 36,621,939 votes for, 7,362,841 against, and 452,368 abstentions. These results indicate approval, supporting continued use of equity-based compensation as part of SCYNEXIS’s overall employee and executive incentive structure.